Research Article
Study on the Relationship between the Use of Bisphosphonates for Antiosteoporosis and Vertebral Re-Fracture after Vertebroplasty
Table 1
Comparison of general data at diagnosis between the surgery group and the combined group.
| | Factors | Operation group (n = 75) | Combined group (n = 75) | t/χ 2) | |
| | Gender | Male | 15 (20.00) | 17 (22.67) | 0.159 | 0.690 | | Female | 60 (80.00) | 58 (77.33) | | Age (years) | 71.80 ± 8.59 | 72.53 ± 8.41 | 0.526 | 0.600 |
| | BMI (kg/m2) | 23.31 ± 4.22 | 22.89 ± 4.16 | 0.614 | 0.540 | | BMD (T) | −3.62 ± 0.74 | −3.59 ± 0.80 | 0.238 | 0.812 | | VAS (分) | 8.05 ± 0.74 | 8.09 ± 0.69 | 0.342 | 0.733 |
| | Fracture site | ≤T10 | 14 (18.67) | 16 (21.33) | 0.187 | 0.911 | | T10∼L2 | 49 (65.33) | 48 (64.00) | | L3∼L5 | 12 (16.00) | 11 (14.67) |
|
|
